ORIGINAL ARTICLE

Cell Research (2008): 549-557
© 2008 IBCB, SIBS, CAS All rights reserved 1001-0602/06 $ 30.00
www.nature.com/cr

MicroRNA let-7b targets important cell cycle molecules in malignant melanoma cells and interferes with anchorage-independent growth

Julia Schultz¹, Peter Lorenz², Gerd Gross¹, Saleh Ibrahim³ and Manfred Kunz¹

Correspondence: Manfred Kunz Tel: +49-381-4949708 E-mail: manfred.kunz@med.uni-rostock.de

Download as printable (PDF) file Full Text (html)file Search Medline for articles by: Julia Schultz

A microRNA expression screen was performed analyzing 157 different microRNAs in laser-microdissected tissues from benign melanocytic nevi (n = 10) and primary malignant melanomas (n = 10), using quantitative real-time PCR. Differential expression was found for 72 microRNAs. Members of the let-7 family of microRNAs were significantly downregulated in primary melanomas as compared with benign nevi, suggestive for a possible role of these molecules as tumor suppressors in malignant melanoma. Interestingly, similar findings had been described for lung and colon cancer. Overexpression of let-7b in melanoma cells in vitro downregulated the expression of cyclins D1, D3, and A, and cyclin-dependent kinase (Cdk) 4, all of which had been described to play a role in melanoma development. The effect of let-7b on protein expression was due to targeting of 3'-untranslated regions (3'UTRs) of individual mRNAs, as exemplified by reporter gene analyses for cyclin D1. In line with its downmodulating effects on cell cycle regulators, let-7b inhibited cell cycle progression and anchorage-independent growth of melanoma cells. Taken together, these findings not only point to new regulatory mechanisms of early melanoma development, but also may open avenues for future targeted therapies of this tumor.

Cell Research (2008) 18:549–557. doi: 10.1038/cr.2008.45; published online 1 April 2008

Keywords: melanoma/skin cancer, cell cyle, cyclins, silencing, reactivation of gene expression